Back to search

Article

Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200,000 men in UK Biobank

2020-03-30

Abstract excerpt

<h4>Background</h4> Insulin-like growth factor-I (IGF-I) and testosterone have been implicated in prostate cancer aetiology. Using newly available data from a large prospective full-cohort with standardised assays and repeat blood measurements, and genetic data from an international consortium, we aimed to investigate the associations of circulating concentrations of IGF-I, sex hormone-binding globulin (SHBG), tot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
88018f01-edc3-5d8c-9cdf-595a31082714
DOI
10.1101/2020.03.27.20044941
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200,000 men in UK BiobankDOI 10.1101/2020.03.27.20044941
Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysisSemantic proximity
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortiaSemantic proximity
Clinical benefits and adverse effects of genetically-elevated free testosterone levels: a Mendelian randomization analysisSemantic proximity
Appraising causal relationships of dietary, nutritional and physical-activity exposures with overall and aggressive prostate cancer: two-sample Mendelian-randomization study based on 79 148 prostate-cancer cases and 61 106 controlsSemantic proximity
Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels.Semantic proximity
Circulating insulin-like growth factor-I and risk of 25 common conditions: outcome-wide analyses in the UK Biobank StudySemantic proximity
Testosterone, sex hormone-binding globulin, insulin-like growth factor-1 and endometrial cancer risk: observational and Mendelian randomization analyses.Semantic proximity
Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Semantic proximity
Circulating Insulin-Like Growth Factor-I and Risk of 25 Common Conditions: Outcome-Wide Analyses in The UK Biobank StudySemantic proximity
Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival.Semantic proximity
Prospective and genetic analyses implicate lower immunosurveillance in the aetiology of prostate cancerSemantic proximity
Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.Semantic proximity
Select a neighboring publication to make it the new centre.